Solid Tumor TIL Therapy Is Infiltrating Multiple Centers With Lympho-“sights” Set on Becoming Standard of Care
Year: 2022
Type: article
Source: The Hematologist
Author: Frederick L. Locke
Institution: Moffitt Cancer Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4205196848
